产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 95% | 询价 | |||
| 5mg | 95% | 询价 | |||
| 10mg | 95% | 询价 | |||
| 50mg | 95% | 询价 | |||
| 100mg | 95% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 95% | 询价 | |||
| 5mg | 95% | 询价 | |||
| 10mg | 95% | 询价 | |||
| 50mg | 95% | 询价 | |||
| 100mg | 95% | 询价 |
CAS No. |
17650-98-5 |
|---|---|
英文名称 |
(3S,6S,9S,15S,18S,21S)-9-((1H-indol-3-yl)methyl)-3-(((S)-1-amino-1-oxo-3-phenylpropan-2-yl)carbamoyl)-21-((S)-5-amino-5-oxo-2-((S)-5-oxopyrrolidine-2-carboxamido)pentanamido)-15-((R)-1-hydroxyethyl)-6-(2-(methylthio)ethyl)-5,8,11,14,17,20-hexaoxo-18-(4-(sulfooxy)benzyl)-4,7,10,13,16,19-hexaazatricosanedioic acid |
别名 |
[TYR(SO3H)4]CAERULEIN;PGLU-GLN-ASP-TYR[SO3H]-THR-GLY-TRP-MET-ASP-PHE-NH2;PYROGLU-GLN-ASP-TYR[SO3H]-THR-GLY-TRP-MET-ASP-PHE-NH2;PYROGLU-GLN-ASP-TYR(SO3H)-THR-GLY-TRP-MET-ASP-PHE-NH2.2NH3;PYR-QD-Y(SO3H)-TGWMDF-NH2;PYR-GLN-ASP-TYR(SO3H)-THR-GLY-TRP-MET-ASP-PHE-NH2;GLP-GLN-ASP-TYR(SO3H)-THR-GLY-TRP-MET-ASP-PHE-NH2;CERULEIN |
标准英文名 |
(3S,6S,9S,15S,18S,21S)-9-((1H-indol-3-yl)methyl)-3-(((S)-1-amino-1-oxo-3-phenylpropan-2-yl)carbamoyl)-21-((S)-5-amino-5-oxo-2-((S)-5-oxopyrrolidine-2-carboxamido)pentanamido)-15-((R)-1-hydroxyethyl)-6-(2-(methylthio)ethyl)-5,8,11,14,17,20-hexaoxo-18-(4-(sulfooxy)benzyl)-4,7,10,13,16,19-hexaazatricosanedioic acid |
分子式 |
C58H73N13O21S2 |
分子量 |
1352.43 |
精确分子量 |
1351.45 |
SMILES |
CSCC[C@H](NC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC1=CC=C(OS(=O)(=O)O)C=C1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCC(=O)N1)[C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(N)=O |
标准SMILES |
C[C@@H](O)[C@H](NC(=O)[C@H](CC1C=CC(=CC=1)OS(O)(=O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCC(=O)N1)C(=O)NCC(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1C=CC=CC=1)C(N)=O |
用途 |
Caerulein is widely used to establish animal models of acute edematous pancreatitis in rats, mice, dogs, and Syrian hamsters; it is applied in vitro for cellular models; it is used for gallbladder function testing; it serves as a tool to study the cellular biology and pathophysiological characteristics of acute pancreatitis (AP) and associated systemic manifestations, including pulmonary alterations in AP, as well as enteroendocrine interactions such as secretin and cholecystokinin (CCK) levels; it is employed to evaluate tissue healing and repair following toxic insult; combined administration of caerulein and lipopolysaccharide (LPS) induces a synergistic effect to generate severe acute pancreatitis models by stimulating pancreatic enzyme secretion and sustained inflammatory cell activation, followed by LPS-mediated dysregulation of inflammatory mediators leading to systemic inflammatory response; caerulein has also been used for the prevention of biliary colic, renal colic, and intermittent claudication pain, and is generally considered an antagonist of endogenous opioid-like substances. |
InChIKey |
YRALAIOMGQZKOW-HYAOXDFASA-N |
|
|
评论 |
|---|